Poster Abstracts - C717

Displaying 50 - 60 of 290
First
4
5
6
7
8
Last

Articles

AT1413: an antibody isolated from a cured Acute Myeloid Leukemia patient that is highly efficacious against AML in vivo
Identification
1058
Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors
Identification
1059
Interleukin-7-producing Genetically Engineered Macrophages as a Tool to Enhance the Efficacy of CAR T Cells in Solid Tumors
Identification
1060
Administration of the synthetic STING agonist ADU-S100 leads to durable anti-tumor immunity via promoting T-cell responses
Identification
1061
A three-dimensional ex vivo platform for assessing targeted immunotherapeutic agents
Identification
1063
A THREE-DIMENSIONAL _EX VIVO_ PLATFORM FOR ASSESSING TARGETED IMMUNOTHERAPEUTIC AGENTS
Activating the immune system: Novel workflows for neoantigen prioritization
Identification
1064
ACTIVATING THE IMMUNE SYSTEM: NOVEL WORKFLOWS FOR NEOANTIGEN PRIORITIZATION
Feasibility of isolating tumor-reactive T cells from peripheral blood of colorectal cancer patients by co-culture with autologous tumor organoids
Identification
1065
Reprogramming of myeloid-derived suppressor cells (MDSC) with RIG-I-like helicases to reinforce tumor therapy
Identification
1067
Targeting Ezh2 selectively impairs intratumoral regulatory T cells to enhance cancer immunity
Identification
1068
The contribution of carbohydrate-dependent interactions in glioblastoma immune escape: New targets for check-point inhibition?
Identification
1069

Displaying 50 - 60 of 290
First
4
5
6
7
8
Last

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.